Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells
Oncotarget | March 4, 2016 | Volume: 7 | Issue: 15 | Pages: 20080-20092
10.18632/oncotarget.7914
| PMID 26956050